These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 31414211)

  • 21. Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation.
    Neyazi S; Yamazawa E; Hack K; Tanaka S; Nagae G; Kresbach C; Umeda T; Eckhardt A; Tatsuno K; Pohl L; Hana T; Bockmayr M; Kim P; Dorostkar MM; Takami T; Obrecht D; Takai K; Suwala AK; Komori T; Godbole S; Wefers AK; Otani R; Neumann JE; Higuchi F; Schweizer L; Nakanishi Y; Monoranu CM; Takami H; Engertsberger L; Yamada K; Ruf V; Nomura M; Mohme T; Mukasa A; Herms J; Takayanagi S; Mynarek M; Matsuura R; Lamszus K; Ishii K; Kluwe L; Imai H; von Deimling A; Koike T; Benesch M; Kushihara Y; Snuderl M; Nambu S; Frank S; Omura T; Hagel C; Kugasawa K; Mautner VF; Ichimura K; Rutkowski S; Aburatani H; Saito N; Schüller U
    Acta Neuropathol; 2024 Jan; 147(1):22. PubMed ID: 38265489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma.
    Araki A; Chocholous M; Gojo J; Dorfer C; Czech T; Heinzl H; Dieckmann K; Ambros IM; Ambros PF; Slavc I; Haberler C
    Acta Neuropathol Commun; 2016 Aug; 4(1):88. PubMed ID: 27550150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRI Phenotype of RELA-fused Pediatric Supratentorial Ependymoma.
    Nowak J; Jünger ST; Huflage H; Seidel C; Hohm A; Vandergrift LA; von Hoff K; Rutkowski S; Pietsch T; Warmuth-Metz M
    Clin Neuroradiol; 2019 Dec; 29(4):595-604. PubMed ID: 30027327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging.
    Pagès M; Pajtler KW; Puget S; Castel D; Boddaert N; Tauziède-Espariat A; Picot S; Debily MA; Kool M; Capper D; Sainte-Rose C; Chrétien F; Pfister SM; Pietsch T; Grill J; Varlet P; Andreiuolo F
    Brain Pathol; 2019 May; 29(3):325-335. PubMed ID: 30325077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intradural extramedullary spinal ependymoma: a benign pathology?
    Robles SG; Saldaña C; Boto GR; Martinez A; Zamarron AP; Jorquera M; Mata P
    Spine (Phila Pa 1976); 2005 May; 30(9):E251-4. PubMed ID: 15864145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment.
    Witt H; Gramatzki D; Hentschel B; Pajtler KW; Felsberg J; Schackert G; Löffler M; Capper D; Sahm F; Sill M; von Deimling A; Kool M; Herrlinger U; Westphal M; Pietsch T; Reifenberger G; Pfister SM; Tonn JC; Weller M;
    Neuro Oncol; 2018 Nov; 20(12):1616-1624. PubMed ID: 30053291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. L1CAM Immunopositivity in Anaplastic Supratentorial Ependymomas: Correlation With Clinical and Histological Parameters.
    Chavali P; Rao S; Palavalasa S; Bevinahalli N; Muthane YTC; Sadashiva N; Santosh V
    Int J Surg Pathol; 2019 May; 27(3):251-258. PubMed ID: 30251576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detecting the long non‑coding RNA signature related to spinal cord ependymal tumor subtype using a genome‑wide methylome analysis approach.
    Wang L; Zhang C; Xie Y; Jiang W; Huang J; Guo S; Xu F; Wang J
    Mol Med Rep; 2019 Aug; 20(2):1531-1540. PubMed ID: 31257484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific expression of PD-L1 in RELA-fusion supratentorial ependymoma: Implications for PD-1-targeted therapy.
    Witt DA; Donson AM; Amani V; Moreira DC; Sanford B; Hoffman LM; Handler MH; Levy JMM; Jones KL; Nellan A; Foreman NK; Griesinger AM
    Pediatr Blood Cancer; 2018 May; 65(5):e26960. PubMed ID: 29350470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spinal Myxopapillary Ependymomas Demonstrate a Warburg Phenotype.
    Mack SC; Agnihotri S; Bertrand KC; Wang X; Shih DJ; Witt H; Hill N; Zayne K; Barszczyk M; Ramaswamy V; Remke M; Thompson Y; Ryzhova M; Massimi L; Grajkowska W; Lach B; Gupta N; Weiss WA; Guha A; Hawkins C; Croul S; Rutka JT; Pfister SM; Korshunov A; Pekmezci M; Tihan T; Philips JJ; Jabado N; Zadeh G; Taylor MD
    Clin Cancer Res; 2015 Aug; 21(16):3750-8. PubMed ID: 25957288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Supratentorial and Infratentorial Ependymoma.
    Myseros JS
    Adv Tech Stand Neurosurg; 2024; 53():93-118. PubMed ID: 39287805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel type of C11orf95-LOC-RELA fusion in a grade II supratentorial ependymoma: report of a case with literature review.
    de Sousa GR; Marie SKN; Oba-Shinjo SM; Ramalho LNZ; Tone LG; Valera ET
    Childs Nerv Syst; 2019 Apr; 35(4):689-694. PubMed ID: 30631904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Classification and neuroimaging of ependymal tumors.
    Mu W; Dahmoush H
    Front Pediatr; 2023; 11():1181211. PubMed ID: 37287627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrative molecular characterization of pediatric spinal ependymoma: the UK Children's Cancer and Leukaemia Group study.
    Ahmad O; Chapman R; Storer LC; Luo L; Heath PR; Resar L; Cohen KJ; Grundy RG; Lourdusamy A
    Neurooncol Adv; 2021; 3(1):vdab043. PubMed ID: 34041479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding Ependymoma Oncogenesis: an Update on Recent Molecular Advances and Current Perspectives.
    Gupta K; Salunke P
    Mol Neurobiol; 2017 Jan; 54(1):15-21. PubMed ID: 26712502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-dose Actinomycin-D treatment re-establishes the tumoursuppressive function of P53 in RELA-positive ependymoma.
    Tzaridis T; Milde T; Pajtler KW; Bender S; Jones DT; Müller S; Wittmann A; Schlotter M; Kulozik AE; Lichter P; Peter Collins V; Witt O; Kool M; Korshunov A; Pfister SM; Witt H
    Oncotarget; 2016 Sep; 7(38):61860-61873. PubMed ID: 27556362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Supratentorial ependymoma in childhood: more than just RELA or YAP.
    Zschernack V; Jünger ST; Mynarek M; Rutkowski S; Garre ML; Ebinger M; Neu M; Faber J; Erdlenbruch B; Claviez A; Bielack S; Brozou T; Frühwald MC; Dörner E; Dreschmann V; Stock A; Solymosi L; Hench J; Frank S; Vokuhl C; Waha A; Andreiuolo F; Pietsch T
    Acta Neuropathol; 2021 Mar; 141(3):455-466. PubMed ID: 33481105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Updates in the classification of ependymal neoplasms: The 2021 WHO Classification and beyond.
    Kresbach C; Neyazi S; Schüller U
    Brain Pathol; 2022 Jul; 32(4):e13068. PubMed ID: 35307892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic characterization of ependymomas reveals 6q loss as the most common aberration.
    Olsen TK; Gorunova L; Meling TR; Micci F; Scheie D; Due-Tønnessen B; Heim S; Brandal P
    Oncol Rep; 2014 Aug; 32(2):483-90. PubMed ID: 24939246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting fibroblast growth factor receptors to combat aggressive ependymoma.
    Lötsch D; Kirchhofer D; Englinger B; Jiang L; Okonechnikov K; Senfter D; Laemmerer A; Gabler L; Pirker C; Donson AM; Bannauer P; Korbel P; Jaunecker CN; Hübner JM; Mayr L; Madlener S; Schmook MT; Ricken G; Maaß K; Grusch M; Holzmann K; Grasl-Kraupp B; Spiegl-Kreinecker S; Hsu J; Dorfer C; Rössler K; Azizi AA; Foreman NK; Peyrl A; Haberler C; Czech T; Slavc I; Filbin MG; Pajtler KW; Kool M; Berger W; Gojo J
    Acta Neuropathol; 2021 Aug; 142(2):339-360. PubMed ID: 34046693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.